Mixed Financial Results for Alliança, Gafisa, and Light in Early 2024

Alliança (AALR3) reported challenging Q1 2024 results. The diagnostic medicine company, formerly known as Alliar, faced an adjusted net loss of R$ 70.8 million ($13.75 million). This represents a 119.8% increase from the same period last year. The company attributed this loss to debt restructuring strategies and capital structure improvements, including significant debt liquidation. Additionally, […]

Leave a Reply

Your email address will not be published. Required fields are marked *